Arnold Library

Frontiers in Tumor Immunotherapy: Blockade of the PD-L1 Inhibitory Ligand

Schoenborn, Jamie (2012) Frontiers in Tumor Immunotherapy: Blockade of the PD-L1 Inhibitory Ligand. Science Spotlight, 2 (7).

[img]
Preview
Text
Frontiers in Tumor Immunotherapy- Blockade of the PD-L1 Inhibitory Ligand.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (276Kb) | Preview
Article URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1200694
Item Type: Article
Additional Information: Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. New England Journal of Medicine. 366:2455-65.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 10 Apr 2015 21:15
Last Modified: 10 Apr 2015 21:15
URI: http://authors.fhcrc.org/id/eprint/925

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy